PAA 2.63% 19.5¢ pharmaust limited

Alzheimer's and Monepantel, page-16

  1. 1,066 Posts.
    lightbulb Created with Sketch. 2158
    Hi Deebo,


    Ferulic acid has iron chelating properties for a possible treatment of Multiple Systems Atrophy and Parkinson's.

    Ferulic acid can affect neurones affected by iron bound to the neurones. The problem seems to be ferroptsis, rust on the neurones as opposed to plaque ( MND) on the neurones. The mTOR inhibitors don't work on " rust" removal , it's on a different lysosomes pathway. I do remember researching it a year or two ago.

    Ferulic acid also needs nanoparticle technology to aid it in crossing the blood brain barrier though.

    That other Company mentioned has a phase two on its compound ATH434 , of which it has achieved an ODD as well. The condition treated is MSA. They have done it hard over the last 7 years I have been invested in. Multiple Systems Atrophy is like MND with chips and salad. Extremely hard to treat. But, they are progressing with it like ourselves, and awaiting
    trial data as well.

    Kpax
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
0.005(2.63%)
Mkt cap ! $94.89M
Open High Low Value Volume
19.0¢ 19.5¢ 19.0¢ $58.40K 305.6K

Buyers (Bids)

No. Vol. Price($)
2 115000 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
19.5¢ 86074 3
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.